Literature DB >> 23199319

Heat shock protein bystander antigens for peptide immunotherapy in autoimmune disease.

E Zonneveld-Huijssoon1, S Albani, B J Prakken, F van Wijk.   

Abstract

Mucosal administration of an antigen eliciting bystander suppression at the site of inflammation results in effective antigen-specific immunotherapy for autoimmune diseases. Heat shock proteins are bystander antigens that are effective in peptide-specific immunotherapy in both experimental and human autoimmune disease. The efficacy of preventive peptide immunotherapy is increased by enhancing peptide-specific immune responses with proinflammatory agents. Combining peptide-specific immunotherapy with general suppression of inflammation may improve its therapeutic effect.
© 2012 The Authors. Clinical and Experimental Immunology © 2012 British Society for Immunology.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23199319      PMCID: PMC3530091          DOI: 10.1111/j.1365-2249.2012.04627.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  94 in total

1.  Heat shock protein 60 sequence comparisons: duplications, lateral transfer, and mitochondrial evolution.

Authors:  S Karlin; L Brocchieri
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-10       Impact factor: 11.205

2.  HLA-E-restricted regulatory CD8(+) T cells are involved in development and control of human autoimmune type 1 diabetes.

Authors:  Hong Jiang; Steve M Canfield; Mary P Gallagher; Hong H Jiang; Yihua Jiang; Zongyu Zheng; Leonard Chess
Journal:  J Clin Invest       Date:  2010-09-27       Impact factor: 14.808

3.  Tools of the trade in vaccine design.

Authors:  A Sette
Journal:  Science       Date:  2000-12-15       Impact factor: 47.728

4.  Anti tumour necrosis-alpha therapy increases the number of FOXP3 regulatory T cells in children affected by Crohn's disease.

Authors:  Ida Ricciardelli; Keith J Lindley; Marco Londei; Sonia Quaratino
Journal:  Immunology       Date:  2008-04-16       Impact factor: 7.397

Review 5.  Heat-shock proteins induce T-cell regulation of chronic inflammation.

Authors:  Willem van Eden; Ruurd van der Zee; Berent Prakken
Journal:  Nat Rev Immunol       Date:  2005-04       Impact factor: 53.106

6.  A conserved mycobacterial heat shock protein (hsp) 70 sequence prevents adjuvant arthritis upon nasal administration and induces IL-10-producing T cells that cross-react with the mammalian self-hsp70 homologue.

Authors:  U Wendling; L Paul; R van der Zee; B Prakken; M Singh; W van Eden
Journal:  J Immunol       Date:  2000-03-01       Impact factor: 5.422

7.  Therapy with the hsp60 peptide DiaPep277 in C-peptide positive type 1 diabetes patients.

Authors:  Volkert A L Huurman; Katelijn Decochez; Chantal Mathieu; Irun R Cohen; Bart O Roep
Journal:  Diabetes Metab Res Rev       Date:  2007-05       Impact factor: 4.876

8.  Parenteral is more efficient than mucosal immunization to induce regression of human papillomavirus-associated genital tumors.

Authors:  Loane Decrausaz; Sonia Domingos-Pereira; Mélanie Duc; Martine Bobst; Pedro Romero; John T Schiller; Patrice Jichlinski; Denise Nardelli-Haefliger
Journal:  Int J Cancer       Date:  2011-08-01       Impact factor: 7.396

Review 9.  Antigen-specific immunotherapy of autoimmune and allergic diseases.

Authors:  Catherine A Sabatos-Peyton; Johan Verhagen; David C Wraith
Journal:  Curr Opin Immunol       Date:  2010-09-17       Impact factor: 7.486

10.  Activation of T cells recognizing self 60-kD heat shock protein can protect against experimental arthritis.

Authors:  S M Anderton; R van der Zee; B Prakken; A Noordzij; W van Eden
Journal:  J Exp Med       Date:  1995-03-01       Impact factor: 14.307

View more
  8 in total

1.  APL-1, an altered peptide ligand derived from heat-shock protein, alone or combined with methotrexate attenuates murine collagen-induced arthritis.

Authors:  Norailys Lorenzo; Fiorella Altruda; Lorenzo Silengo; Maria Del Carmen Dominguez
Journal:  Clin Exp Med       Date:  2016-05-09       Impact factor: 3.984

2.  APL1, an altered peptide ligand derived from human heat-shock protein 60, increases the frequency of Tregs and its suppressive capacity against antigen responding effector CD4 + T cells from rheumatoid arthritis patients.

Authors:  Ariana Barberá; Noraylis Lorenzo; Peter van Kooten; Joel van Roon; Wilco de Jager; Dinorah Prada; Jorge Gómez; Gabriel Padrón; Willem van Eden; Femke Broere; María Del Carmen Domínguez
Journal:  Cell Stress Chaperones       Date:  2016-05-30       Impact factor: 3.667

3.  HSP60: a double edge sword in autoimmunity.

Authors:  Dorit Landstein; Rina Ulmansky; Yaakov Naparstek
Journal:  Oncotarget       Date:  2015-10-20

Review 4.  T Cell-Mediated Chronic Inflammatory Diseases Are Candidates for Therapeutic Tolerance Induction with Heat Shock Proteins.

Authors:  Ariana Barbera Betancourt; Qingkang Lyu; Femke Broere; Alice Sijts; Victor P M G Rutten; Willem van Eden
Journal:  Front Immunol       Date:  2017-10-26       Impact factor: 7.561

Review 5.  The Pathophysiological Role of Heat Shock Response in Autoimmunity: A Literature Review.

Authors:  Ariadni Androvitsanea; Kostas Stylianou; Eleni Drosataki; Ioannis Petrakis
Journal:  Cells       Date:  2021-10-01       Impact factor: 6.600

Review 6.  Heat shock proteins: Biological functions, pathological roles, and therapeutic opportunities.

Authors:  Chen Hu; Jing Yang; Ziping Qi; Hong Wu; Beilei Wang; Fengming Zou; Husheng Mei; Jing Liu; Wenchao Wang; Qingsong Liu
Journal:  MedComm (2020)       Date:  2022-08-02

Review 7.  Role of heat shock proteins in aging and chronic inflammatory diseases.

Authors:  Christian R Gomez
Journal:  Geroscience       Date:  2021-07-09       Impact factor: 7.713

Review 8.  Skewed Helper T-Cell Responses to IL-12 Family Cytokines Produced by Antigen-Presenting Cells and the Genetic Background in Behcet's Disease.

Authors:  Jun Shimizu; Fumio Kaneko; Noboru Suzuki
Journal:  Genet Res Int       Date:  2013-12-30
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.